Generate a tailored SOP for Dr. Garret Fitzgerald. Improve your application with a focused, well-structured draft.
Garret FitzGerald is the Robert L. McNeil, Jr. Professor of Translational Medicine and Therapeutics at the University of Pennsylvania. His research primarily focuses on prostanoid biology, the role of peripheral molecular clocks in cardiovascular biology, metabolism, and aging. He is known for his work on the interdisciplinary nature of translational science in medicine. FitzGerald's laboratory investigates drug actions in humans through model systems including mammalian cells, worms, fish, and mice. His research utilizes mass spectrometry to study lipidomes and proteomes. Notably, he has explored different aspects of prostanoid research, looking at the comparative efficacy and safety of COX inhibitors and the potential countervailing actions of prostanoids in stem cell differentiation. FitzGerald is also involved in the PENTACON consortium, which aims to integrate basic and clinical research across various biological systems to predict NSAID efficacy and cardiovascular hazard in patients.
University of Pennsylvania • Philadelphia, PA
Leading research in translational medicine and therapeutics.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.